Kylin Therapeutics, Inc. Announces New Patent Surrounding pRNAi Technology

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Officials of Kylin Therapeutics Inc., a leading RNAi company, announced this week that they received an issued patent from the U.S. Patent and Trademark Office (USPTO).
MORE ON THIS TOPIC